A share price of Agios Pharmaceuticals Inc [AGIO] is currently trading at $43.63, down -0.52%. An important factor to consider is whether the stock is rising or falling in short-term value. The AGIO shares have gain 7.70% over the last week, with a monthly amount glided 8.42%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Agios Pharmaceuticals Inc [NASDAQ: AGIO] stock has seen the most recent analyst activity on February 24, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $58. Leerink Partners downgraded its rating to a Market Perform and decreased its price target to $56 on September 27, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight. Piper Sandler started tracking with a Overweight rating for this stock on February 03, 2023, and assigned it a price target of $41. In a note dated November 17, 2022, Goldman upgraded an Neutral rating on this stock and boosted its target price from $17 to $32.
Agios Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $23.42 and $62.45. Currently, Wall Street analysts expect the stock to reach $56 within the next 12 months. Agios Pharmaceuticals Inc [NASDAQ: AGIO] shares were valued at $43.63 at the most recent close of the market. An investor can expect a potential return of 28.35% based on the average AGIO price forecast.
Analyzing the AGIO fundamentals
Trailing Twelve Months sales for Agios Pharmaceuticals Inc [NASDAQ:AGIO] were 44.79M which represents 43.69% growth. Gross Profit Margin for this corporation currently stands at 0.84% with Operating Profit Margin at -10.62%, Pretax Profit Margin comes in at -9.16%, and Net Profit Margin reading is -8.96%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.28 and Total Capital is -0.36. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.04 points at the first support level, and at 42.44 for the second support level. However, for the 1st resistance point, the stock is sitting at 44.39, and for the 2nd resistance point, it is at 45.14.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Agios Pharmaceuticals Inc [NASDAQ:AGIO] is 13.82. On the other hand, the Quick Ratio is 13.39, and the Cash Ratio is 1.24. Considering the valuation of this stock, the price to sales ratio is 56.80, the price to book ratio is 1.98.
Transactions by insiders
Recent insider trading involved SARAH GHEUENS, Officer, that happened on Nov 11 ’25 when 2454.0 shares were purchased. Chief Medical Officer, Gheuens Sarah completed a deal on Oct 30 ’25 to sell 200.0 shares. Meanwhile, Officer SARAH GHEUENS bought 200.0 shares on Oct 30 ’25.
